搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按相关度排序
按时间排序
1 天
Seniors Shielded: New RSV Vaccine Shows 80% Effectiveness
Recent findings from a multi-state study reveal that the RSV vaccine is approximately 80% effective in preventing severe ...
2 天
Just After Pfizer's RSV Vaccine Approval For Younger Adults, GSK Layouts Encouraging ...
GSK unveils new Arexvy data showing strong protection in adults 18-49 at risk for RSV. The vaccine could broaden coverage for ...
4 天
US FDA approves Pfizer's RSV vaccine for adults at increased risk of the disease
The U.S. Food and Drug Administration on Tuesday approved Pfizer's RSV vaccine for the prevention of lower respiratory tract ...
The American Journal of Managed Care
4 天
FDA Approves Abrysvo RSV Vaccine for Adults at Increased Risk
Abrysvo is the first and only respiratory syncytial virus (RSV) vaccine indicated for adults younger than 50 years.
Medpage Today on MSN
4 天
FDA Expands Approval of RSV Vaccine Abrysvo to Include All At-Risk Adults
The FDA expanded the approval of the bivalent RSV prefusion F (RSVpreF) vaccine (Abrysvo) to include the prevention of lower ...
Medpage Today on MSN
7 天
RSV Vaccine Tied to Fewer Hospitalizations, ED Visits in Older, High-Risk Adults
The respiratory syncytial virus (RSV) vaccine (Abrysvo) was linked with fewer hospitalizations and emergency department (ED) ...
4 天
on MSN
Pfizer Receives Expanded FDA Approval for RSV Vaccine
Abrysvo can prevent lower respiratory tract disease caused by RSV for people between the ages of 18 and 59 who are at ...
BioSpace
4 天
Pfizer Wins FDA Approval of RSV Vaccine for Broader Adult Population
Pfizer’s Abrysvo is the first respiratory syncytial virus vaccine that can be used for adults less than 50 years of age.
8 天
Study confirms RSV vaccine's protective power for seniors
A global real-world study of the vaccine for respiratory syncytial virus (RSV) finds it offers folks aged 60 and over 80% ...
BioPharma Dive
4 天
Pfizer’s RSV vaccine cleared by FDA for use in some younger adults
Approval of Pfizer's Abrysvo in certain adults aged 18 to 59 years old will substantially expand the number of people ...
WZZM on MSN
3 天
Experts encourage pregnant women to get the RSV vaccine before cases begin to rise
Which is why doctors and health experts are encouraging people to get the RSV vaccine now. That includes. Dr. Eryn Hart from ...
9 天
on MSN
Study finds RSV vaccine highly effective in protecting older adults against severe disease ...
A multi-state study, published in The Lancet, is one of the first real world data analyses of the effectiveness of the ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈